Background: Errors in medication use are a patient safety concern globally, with different regions reporting differing error rates, causes of errors and proposed solutions. The objectives of this review were to identify, summarise, review and evaluate published studies on medication errors, drug related problems and adverse drug events in the Gulf Cooperation Council (GCC) countries. Methods: A systematic review was carried out using six databases, searching for literature published between January 1990 and August 2016. Research articles focussing on medication errors, drug related problems or adverse drug events within different healthcare settings in the GCC were included. Results: Of 2094 records screened, 54 studies met our inclusion criteria. Kuwait was the only GCC country with no studies included. Prescribing errors were reported to be as high as 91% of a sample of primary care prescriptions analysed in one study. Of drug-related admissions evaluated in the emergency department the most common reason was patient non-compliance. In the inpatient care setting, a study of review of patient charts and medication orders identified prescribing errors in 7% of medication orders, another reported prescribing errors present in 56% of medication orders. The majority of drug related problems identified in inpatient paediatric wards were judged to be preventable. Adverse drug events were reported to occur in 8.5-16.9 per 100 admissions with up to 30% judged preventable, with occurrence being highest in the intensive care unit. Dosing errors were common in inpatient, outpatient and primary care settings. Omission of the administered dose as well as omission of prescribed medication at medication reconciliation were common. Studies of pharmacists' interventions in clinical practice reported a varying level of acceptance, ranging from 53% to 98% of pharmacists' recommendations. Conclusions: Studies of medication errors, drug related problems and adverse drug events are increasing in the GCC. However, variation in methods, definitions and denominators preclude calculation of an overall error rate. Research with more robust methodologies and longer follow up periods is now required. Ó 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Background
The use of medication is perhaps the most common intervention in medical practice. Medication use occurs in many different settings and involves different health care practitioners, as well as patients and their carers (Franklin and Tully, 2016) . There are different types of problems associated with medication use, some are preventable events, some are not, and some result in and some do not. Medication errors (ME), are a global health care concern with the majority of research published from developed countries such as the United States of America and Europe (Morimoto et al., 2010) and (Jha et al., 2010) and much less information on the incidence and types of errors within the Middle East and the GCC in particular.
The GCC comprises six countries: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE). These countries are listed by the United Nations World Bank as high income countries (World Bank, 2017) . Total expenditure on health as a percentage of the country's gross domestic product ranged from 2.2% to 5% in 2014 (World Health Organization, 2014) . The GCC countries' health systems are also comparable and are more similar to each other than to other countries within the Eastern Mediterranean Region or other Middle Eastern countries.
A previous systematic review of MEs across the whole of the Middle East concluded that 'the main factor contributing to MEs [. . .] is poor knowledge of medicines by both doctors (prescribers) and nurses (administering drugs). ' (Alsulami et al., 2013) . Publications specifically from the GCC region report ME as an issue within both primary care and the inpatient setting (Al Khaja et al., 2005; Al Khaja et al., 2007; Al-Dhawailie, 2011) . However, ME terminology used among the studies is different, as are the different types of medication safety aspects studied. The concept of ''medication safety" potentially encompasses a wide range of areas (AckroydStolarz et al., 2006; McLeod, 2016) . We therefore aimed to conduct an updated systematic review of medication safety research from the GCC countries in order to describe the breadth of problems associated with medication use. This will enable a more complete representation of what has been explored in this region regarding medication errors and helps identify gaps in the literature and focusses on preventable harm relating to medication use in clinical practice. Our objectives were to summarise and evaluate quantitative as well as qualitative evidence published on MEs, drug related problems (DRPs) and adverse drug events (ADEs) within the GCC region and to make recommendations for addressing any gaps in the literature identified.
Methods

Data sources and search strategy
The following electronic databases were searched for the period 1 January 1990 to 31 August 2016: CINAHL Plus, EMBASE, International Pharmaceutical Abstracts, PubMed (MEDLINE), ScienceDirect, and Web of Science. Bibliographies of relevant publications were also hand searched.
The search strategy was tailored to each database and medical search headings (MeSH terms) were also utilised for PubMed (MEDLINE). One author (JAS) screened the titles and abstracts of all 3115 records identified, for relevance and to determine if the complete text should be retrieved for comparing against inclusion/exclusion criteria and potential inclusion to the review. A random 10% sample was then screened by a second reviewer NAS to assess reliability. Cohen's kappa (K) value (Cohen, 1960) was calculated to be 0.568; according to Landis and Koch (1977) this is interpreted as indicating moderate agreement. Any differences in opinion about the relevance of the papers were resolved by discussion. For final study selection, the full text was assessed by JAS; any uncertainty was referred to NAS. Any cases of disagreement were referred to BDF, with further clarification and consultation undertaken by JP and HA as needed. Details of the protocol were registered with the PROSPERO international prospective register of systematic reviews (reference CRD42016038733).
Study selection 2.2.1. Inclusion criteria
Research articles focussing on medication errors in the GCC countries published in English or Arabic were included. Both qualitative and quantitative studies of all study designs were included. Relevant conference abstracts were also included given the anticipated paucity of published full text research articles within the GCC. Studies on prescribing, dispensing, administration and monitoring errors in inpatient, hospital outpatient and primary care settings whether hospital or community pharmacies were included. Also included for review were studies examining administration errors by patients/caregivers in their own homes as well as original descriptive research on medication reconciliation errors and medication history errors (errors in the process of documenting the medications the patient is taking or used to take). According to the definitions utilised by the Saudi Arabian Ministry of Health the term ME was defined as: ''Any preventable event that may cause or lead to inappropriate use or patient harm while the medication is in the control of the health care professional, patient or consumer" (Saudi Arabian Ministry of Health, 2012) . Studies assessing DRPs and ADEs, (both preventable and non-preventable) potentially inappropriate medications (PIMs) were also included. Lastly, studies of pharmacists' interventions to reduce MEs, ADEs or DRPs were also reviewed for inclusion. Studies meeting the review inclusion criteria were included in the analysis.
Exclusion criteria
Letters, opinion pieces, editorials and case reports were excluded. Studies focussing on expected side effects occurring with the proper use of a medication were also excluded, where a side effect was defined as: ''An expected, well known reaction that results in little or no change in patient management" (Ninno and Ninno, 2000) . Research concerned with blood/blood products, parenteral and enteral nutrition was excluded. Systematic reviews that had studies involving the GCC countries among their review of studies were not included in the review but used as a potential source to identify further relevant studies for inclusion. Finally, articles associated with attitudes, perceptions, or views on clinical services were excluded.
Process of data extraction
Search results were exported to Endnote X7 (Thomson Reuters, Times Square New York, NY, USA).
Duplicates were removed. Article titles and abstracts were initially screened for relevance to the systematic review inclusion and exclusion criteria, followed by full text retrieval analysis. Any ambiguities were discussed with BDF and NAS. Further clarification and consultation was undertaken by JP and HA if needed. Data from included studies was extracted on to a data collection sheet developed for this purpose. The extracted data comprised of country, setting and data collection duration, study design, definitions used for study outcomes, the medication safety aspect analysed method of error identification, and reported results. The extraction form was completed by JAS and reviewed by NAS and BDF. Any discrepancies were resolved by discussion with the remaining authors.
Quality assessment
Quality assessment of the reviewed included studies was carried out by JAS and NAS with any remaining uncertainties directed to and resolved by BDF. The quality assessment was carried out as part of the analysis of the included studies; study quality was based on specific aspects relating to medication safety research (e.g. methods used for identifying medication errors). The studies were therefore reviewed according to 15 criteria (Appendix B) adapted from previous studies (Allan and Barker, 1990; Ghaleb et al., 2006; Alsulaimi et al., 2013; McLeod et al., 2013) . The first thirteen criteria are relevant to all medication error study types, while the remaining two apply only to studies of administration error. Any criteria not applicable to the study design were classified as 'not applicable' For the purpose of this study it was decided to assess the quality of the conference abstracts by adapting same criteria as for full text articles, as there are no is universally accepted criteria to evaluate conference abstracts.
Results
Search results
The search yielded a total of 3115 hits; an additional two were identified via search of bibliographies to give a total of 3117. After duplicate removal, the number of records remaining was 2094. All studies identified were in English, no studies in Arabic were identified. Following initial screening, 294 records were assessed as being potentially relevant. Following full text screening, 54 studies were identified for inclusion: 42 full papers and 12 conference abstracts (Fig. 1) .
The geographical distribution of the studies (Fig. 2) reveals that the majority of the studies were carried out in Saudi Arabia. None of the included studies were conducted in Kuwait.
Quality assessment
Quality of the studies varied (Appendix B). Many studies did not specify a definition for ME, and/or the categories of ME included. Criteria 14 and 15 were only applicable to three studies, one abstract by Aljamal (2012) and two full text studies, by Almazrou et al. (2015) and by Sadat-Ali et al. (2010) . Most studies adequately described the setting and study objectives. Only six of the 54 studies adequately described sample size calculations. The majority of the conference abstracts did not meet quality assessment criteria such as the inclusion of sample size calculations, validity and reliability, study limitations or details of ethical approval, most likely due to their limited word count.
Description of included studies
Studies were classified within five main categories, with studies of ME further categorised into six subcategories (Fig. 3) .
The following is a summary of the characteristics of the included studies; more details are given in Appendix D. It was Records excluded (n = 1798) due to: Duplicate (n=64) Not relevant to the topic (n=1550) Not in GCC region (n=120) Not in English or Arabic (n=40) Fits exclusion criteria (n=24)
Records excluded (n = 240) due to: Duplicate (n= 11) Not relevant to the topic (n= 163) Not in GCC region (n= 19) Fits exclusion criteria (n= 17) Case study, report, opinion, editorial, letter (n= 28) Unable to obtain (n= 2)
noticed that drug classes commonly studied were antibiotics (Al Khaja et al., 2006; Alanazi et al., 2015) and drug classes used inappropriately were benzodiazepines and tri-cyclic antidepressants (Al Omar et al., 2013) .
3.3.1. Studies describing medication errors 3.3.1.1. Studies describing prescribing errors. Seventeen studies described prescribing errors. Seven were cross-sectional audits of prescriptions (Al Khaja et al., 2005; 2008; Khoja et al., 2011; Al-Hussein, 2008; Albarrak et al., 2014) ; all studied handwritten prescriptions except for Albarrak et al. (2014) who included both handwritten and electronic prescriptions. Five were retrospective audits (Al Khaja et al., 2012; Altebenaui et al., 2015; Al Shahaibi et al., 2012; Irshaid et al. 2005; Aseeri 2013 ), as well as three retrospective analyses of patient charts Aljeraisy et al. 2011; Youssef et al. 2015) and two crosssectional chart reviews (Alanazi et al. 2015; Al-Dhawailie, 2011) . Data collection periods ranged from two weeks to three years. Common prescribing error definitions were those of Dean et al. (2000) and Neville et al. (1989) . Appendix C gives more information on the definitions. Ten studies were conducted within a primary care or outpatient care setting while the remaining four related to the hospital setting. Two studies assessed prescriptions from inpatient and outpatient setting. Within outpatient and primary care settings, the prevalence and types of prescribing errors have been described for infants as well as adults. In a study analysing prescriptions issued for infants (Al Khaja et al., 2007) approximately 91% of prescriptions contained an error. In another study by Al Khaja et al. (2006) , approximately one fifth of infants were prescribed antibiotics at subtherapeutic doses. For adults, studies report varying results, ranging from approximately 7% as reported by Al Khaja et al. (2005) , to 18% of prescriptions containing errors (Khoja et al. 2011) . Al Khaja et al. (2012) revealed approximately one quarter of prescriptions ordered by two-thirds of primary care physicians had errors. Other studies reported up to 50% of prescriptions missing at least one item of information (Altebenaui et al. 2015) . Furthermore up to 88% of prescriptions written by junior doctors were identified to contain major errors of omission and commission or errors of integration (Al Khaja et al., 2008) . Errors of integration or knowledge-based errors in prescribing were defined in the study to include potential drug-drug interactions or drug allergies, which may reflect a failure of the prescriber to integrate information about the patient or drug history (Al Khaja et al., 2008 ). An Omani study by Al Shahaibi et al. (2012) found that different kinds of omission error were evident in up to 72% of prescriptions. While Irshaid et al. (2005) reported, from their analysis of prescriptions, that physicians' handwriting was illegible in approximately 64% of prescriptions. In 2015, Alanazi, Aljeraisy, Salam reported that the prevalence of inappropriate antibiotic prescriptions with at least one or more types of error was significantly higher among paediatric patients compared to adult patients. In 2008 Al-Hussein carried out a study in which prescriptions were checked for compliance with 14 components of local guidelines; 87% of prescriptions did not meet these requirements (AlHussein, 2008) .
Regarding prescribing errors within an inpatient setting, following analysis of inpatient handwritten medication charts and medication orders, Mahmoud et al. (2016) , reported that the incidence of prescribing errors was 3.6 (95% CI, 3.3-3.9) per 100 prescriptions, 33.9 (95% CI, 31.5-36.6) per 100 admissions and 76.5 (95% CI, 70.9-82.3) per 1000 patient days. Al-Dhawailie (2011) reported approximately 7% of medication orders had prescribing errors. Aljeraisy et al. (2011) reported that in a tertiary paediatric inpatient setting in Saudi Arabia, the overall error rate was 56 per 100 medication orders (95% CI: 54.2%, 57.8%). Dosing errors were most prevalent error type in all three studies. In a Saudi Arabian study by Youssef et al., (2015) on types of contraindicated medications, approximately 14% of the contraindicated medications that resulted in a computerised prescribing system alert were still administered to patients with renal insufficiency by the ordering physician.
Two studies assessed prescribing errors from more than one hospital area. In 2014 Albarrak et al. compared handwritten and electronic prescriptions in primary care and outpatient surgery setting and inpatient respectively, for legibility, completeness and medication errors. A statistically significant difference was identified (P < 0.001) between handwritten and e-prescriptions in omitted dose and omitted routes of administration. One study described the use of a tool to decrease problems associated with medication use, retrospectively reviewing prescriptions from outpatient, inpatient and emergency department settings (Aseeri, 2013) . This study reported the outcome of introducing an antibiotic dosing standardisation policy and its reduction of prescribing errors. Physicians were vigilant in documenting patient weight on prescriptions after the implementation of standardized dosing policy, and dosing errors identified on prescriptions reduced from approximately 34% of prescriptions pre-implementation phase to approximately 5% of prescriptions analysed after the implementation phase, a statistically significant reduction.
3.3.1.2. Studies describing administration errors. Two studies were identified, both observational in nature, where observation of medication administration was the method of data collection. One was carried out in an outpatient pharmacy waiting area, and the other in the inpatient setting. In the outpatient setting, Almazrou et al. (2015) , revealed that 58% of mothers (patient carers') measured an accurate dose of paracetamol using an oral syringe versus 50% of mothers using a dropper and 51% using a dosing cup. Dosing accuracy for each type of instrument was influenced by the mothers' education status. Aljamal (2012) observed nurses during medication administration in the inpatient setting. A total of 169 medication administration errors were observed of 2112 opportunities for error, representing an error rate of 8%. The most common errors were wrong time, dose omission, and wrong dose.
3.3.1.3. Studies assessing errors in medication history and medication reconciliation errors. There were several methods used by the five studies of medication reconciliation or medication history errors. Pharmacists screened the patient chart and performed interviews to identify discrepancies at admission or at discharge, triage or transfer between inpatient wards; and then compared with patient medical record or patient discharge medication list (Abu Yassin et al. 2011 , Aljadhey and Al-Rashoud 2013 , Al Anany et al., 2012 Rehmani 2011) . Another study developed a medication reconciliation (MR) form as a tool to detect medication discrepancies (Sonallah et al. 2014 Perceptions of HCP on ME and ME reporting (n=3)
Abbreviations used: ADE-Adverse drug event DRP-Drug related problems HCP-healthcare professional or healthcare practitioner ME-medication error PIM-Potentially inappropriate medication Al-Rashoud, 2013) and Sonallah et al., (2014) . The most common types of unintended medication discrepancies were medication omissions, followed by errors in dosages.
3.3.1.4. Studies assessing potentially inappropriate medications (PIM) use. Two studies, both from Saudi Arabia, assessed PIMs in elderly. Al-Omar et al. (2013) reported that approximately 44% of the patients had filled a prescription for at least one PIM in the outpatient setting, and Al Odhayani et al. (2016) reported that approximately 53% of the elderly participants attending appointments in the outpatient clinics or as part of home health care programme were using one or more PIMs. Harm caused by these PIMs was not assessed.
3.3.1.5. Studies assessing more than one type of medication error. 'Overall, eight studies reported more than one type of medication error. Two studies were retrospective in designs. The first, a retrospective study by Dibbi et al. (2006) reviewed medical records for adult hospitalised patients for 2 years and reported that the most common type of error was wrong strength (concentration). The second, a retrospective study by Alakhali et al. (2014) reviewed prescriptions from the outpatient setting for two months and identified 1850 opportunities for error and 201 (10.9%) prescribing, dispensing and administration errors. Five studies assessed more than one type of medication errors using incident reports. The following studies all took place in large tertiary care hospitals in Saudi Arabia. Incidents were reported at a rate of 5.8 per 1000 patient days as stated by Arabi et al. (2012) . Medication errors made up approximately 7% of all incident reports from the hospital and approximately 13% of all incident reports from the ICU. In a study by Alshaikh et al. (2013) , the medication error rate over the 1-year study period was 0.4% (949 medication errors for 240,000 prescriptions), approximately 2% of the medication errors were categorised as resulting in any harm to the patient. Medication errors were reported to have originated predominantly at the prescribing stage of the medication process. In the third study, all medication error incident reports collected in the two year period were analysed (Sadat-Ali et al., 2010) , and 38 medication errors reported from 23,597 admissions, giving a medication error reporting rate of 0.15% per admission. The fourth study was specific to a neonatal intensive care unit (Hemida et al., 2011) , estimating an incidence of one report involving medication error per 250 admissions, with antibiotics most commonly involved. The last study (Al-Khani et al., 2014) determined 10% of prescribing errors included in the hospital reporting system were identified by pharmacists to be prescribing errors involving the wrong drug.
The remaining study by Elnour et al. (2007) reported the impact of the structured educational programme for inpatient nursing staff on the usage of MedSafe tool, a medication error reporting program launched in all inpatient nursing stations. Results indicated an increase in the number of ME reported to the Med Safe Tool after the structured program, the types of errors most often reported were monitoring errors and dosage errors.
Studies of DRPs
Five studies assessed DRPs. All five differentiated preventable and non-preventable DRPs. The DRP definition and classification of the Pharmaceutical Care Network in Europe (PCNE 2006, and was used by two studies (Rashed et al., 2012; Al Hamid et al., 2016) . Three studies (Al-Olah and Al Thiab, 2008, Al-Arifi, 2014; Alghamdy et al. 2015) defined DRPs according to the definition of Strand et al. (1990) . The different DRP categories identified across all five studies included adverse reactions, drug choice problems, dosing problems, and interactions. Pharmacists' clinical interventions on identification of DRPs were at the prescriber level, patient/caregiver level, and the drug level. Al-Olah and Al Thiab (2008) reported that the most common definite DRP-related admission to hospital was due to failure to receive medications accounting for approximately 47% of all DRPs, followed by adverse drug reactions approximately 25% of all identified DRPs respectively. Al-Arifi, 2014 reported approximately 19% of patients presented to the emergency department due to DRPs and approximately 93% of these patients needed hospital admission. The most common DRPs were adverse drug reactions (ADRs) and patients' non-adherence. Alghamdy et al. (2015) reported approximately 5% of admissions were due to DRPs, 70% of which were preventable. Rashed et al. (2012) assessed attendance of paediatric patients to the emergency department and DRP incidence was reported as approximately 29%; the majority were judged preventable. Al Hamid et al. (2016) , randomly selected 150 patient medical records from all admissions for patients over 18 years of age and identified 94 MRPs, of which 67% were definite (actual as defined by PCNE 2010, based on personal communication Alhamid, October 2017), while 33% were probable (potential as defined by PCNE 2010). Major risk factors associated with MRPs were polypharmacy and patient non-adherence.
Studies assessing adverse drug events
Three studies assessed ADE. A study from UAE, by Al-Tajir and Kelly (2005), compared two methods to detect ADEs. The first method of data collection for ADEs was limited to spontaneous reporting. For the second arm of the study active monitoring for ADEs took place. It was concluded that the incidence of ADEs detected through surveillance (active monitoring) was significantly higher than for ADEs reported spontaneously for both inpatients and outpatients. About 56% of ADEs identified by both methods combined were judged definite or probable and, of these, approximately 14% were consistently judged preventable.
In Saudi Arabia, Aljadhey et al. (2013) determined the incidence of in-hospital ADEs and assessed their severity and preventability in an academic tertiary hospital. Incidents were identified through a combination of medical record review by study pharmacists and voluntary reports from other health care professionals. The incidence of ADEs was 8.5 per 100 admissions. Incidences of preventable and non-preventable ADEs were 2.6 and 6 per 100 admissions respectively. In a more recent study, Aljadhey et al. (2016) determined the incidence of in-hospital ADEs and assessed their severity and preventability in four hospitals in Saudi Arabia. Incidents were identified as described in the study above (Aljadhey et al. 2013) . Authors used a variety of ages to differentiate adults from children. The incidence of ADEs per 100 admissions was 6.1 and the incidence of potential ADEs was 16.9 per 100 admissions where a potential ADE was defined as an error that carried a risk of causing injury related to the use of a medication but harm did not occur, either because of specific circumstances or because the error was intercepted (Morimoto et al. 2004 ).
Studies of pharmacists' interventions
Nine studies focused on pharmacists' interventions, these had a variety of designs and interventions were aimed to address assessment/reduction of medication errors or problems associated with medication use. The interventions included pharmacists' documentation of interventions on prescriptions on the inpatient ward, or in primary care clinics; pharmacist performing medication use reviews pharmacist counselling to patients, pharmacist education to physicians. The first was a conference abstract (Rahman et al., 1994) in which authors documented interventions on prescriptions with an intervention rate (error rate) was 1.3%. Al-Rashdi et al. (2010) , Al Rahbi et al., (2014) both studies from Oman. Hooper et al. (2009) , was a study from Qatar. These three studies documented pharmacists' interventions on prescriptions and reported rates of interventions acceptance ranging from 53% up to approximately 98% of all suggested interventions. Al-Ghamdi et al. (2012) , reported benefits of comprehensive pharmacist counselling. There was a significant difference in the occurrence of ADEs between the control group (no pharmacist counselling) and intervention group. In the control group, 61% of ADEs were judged preventable, and 39% were judged to be serious. Al-Jazairi et al. (2008) studied the participation of a clinical pharmacist in an ICU setting, reporting that the medical team accepted approximately 95% of the interventions. The main DRPs were: no drug prescribed for the medical condition, inappropriate dosing regimen and no indication for drug use. Mitwally et al. (2015) in Qatar reported a 52% reduction in prescribing errors after the prescribing physicians attended educational sessions prepared by the clinical pharmacy team. Rashed et al. (2012) investigated DRPs in hospitalised children and 258 DRP were identified for 186 children. The median number of DRPs per patient was one. Dosing problems were the most common, followed by drug choice problems and ADRs. Regarding the interventions, approximately 43% of all interventions were at drug level, approximately 40% of interventions at prescriber level and approximately 10% of interventions were done at patient/caregiver level. Kheir et al. (2014) reported the results of their exploratory study of conducting interviews as part of medication use reviews within a primary health care facility in Qatar. The most commonly encountered DRPs were non-adherence and adverse drug reactions.
Studies on perceptions of health care practitioners towards medication errors
Three studies considered this topic; all were conducted in Saudi Arabia. Al-Rowibah et al. (2013) reported the findings on the impact of computerised physician order entry (CPOE): 72% of physicians agreed that CPOE helped them to decrease ADEs, but 55% reported that it created new types of errors. Al-Arifi, 2014 reported the results of a validated questionnaire to community pharmacists on dispensing errors. The majority of respondents indicated that the risk of dispensing errors was increasing and most of them were aware of dispensing errors. Al Anazi and AlJeraisy (2015) used a survey to collect information on healthcare professionals' perceptions towards contributing factors of medication error (ME) occurrence. Some of the underlying factors of MEs reported were interruptions while writing the order, lack of clarity of physicians order, and no double-checking of the doses.
Discussion
Key findings
Fifty-four studies were identified that met our inclusion criteria; the majority were conducted in Saudi Arabia. No articles from Kuwait met inclusion criteria while only two were from the UAE. Notably, Kuwait is the only one of the six that is not a member of the Uppsala Monitoring Centre which is part of the WHO Programme for International Drug Monitoring (WHO Collaborating Centre for International Drug Monitoring, 2017). Saudi Arabia is the largest and has the highest population of the GCC countries, all of which are factors that may account for the larger number of studies from this country. None of the included studies had a qualitative study design, and it may therefore be important to supplement quantitative studies with qualitative research to help understanding of the causes of medication errors and other problems, as well as identifying barriers and facilitators to addressing them.
Interpretation
Only one study was related to the community pharmacy setting (Al-Arifi ,2014). The studies concerning incident reporting were all in tertiary care hospitals in large cities of Saudi Arabia, with only one study educating staff on usage of a medication error reporting tool in Qatar. It is important to encourage a culture of 'no blame' across the GCC, and attempts to report and therefore analyse incidents in smaller healthcare institutions would help identify unique issues faced by the practitioners in these establishments. There was a lack of medication safety studies in health care settings of rural areas. Few studies had a multi-site setting described, which would make generalisation of results more difficult. In addition, studies identified errors and provided recommendations but there were few follow up studies of strategies to address them. Multidisciplinary research is a concept that could be integrated within curricula of medical schools, pharmacy schools and allied health sciences for enhanced collaboration in focusing on medication safety. Lack of standardised terminology related to ME studies has been reported internationally (Lisby et al., 2010) and the studies included in this review also used a variety of definitions to determine study outcomes as shown in Appendix C. Even among younger patients or elderly patients, there is a variety of definitions used as to what comprises a medication error or what comprises a drug related problem, even from within the same country. This is in agreement with (Alsulaimi et al., 2013) .
Recommendations
These findings highlight the need to attempt to standardise GCC terminology related to ME and ADRs and create a unified platform to establish patient safety. It must also be kept in mind that in studies of voluntary reporting, the hospital culture and environment must be considered. Furthermore these reported numbers are an underrepresentation of reality as data from rural areas has not been reported, perhaps incentive scheme for reporting in rural health areas should be explored. Patient interactions, factors which would affect their adherence are worth exploring, various studies reviewed identified that patient non-compliance was a factor in emergency department use, and in interventional studies, only 10% of interventions were recorded on the patient level. Understanding of whether there are specific reasons and identifying of issues existing with patients in the GCC is a step closer to developing practical solutions.
In recent years, advances in technology has played a big part in evolution of medication prescribing and administration; research evaluating the use of such technology should be encouraged and supported. The majority of studies were descriptive (n = 43) while only 11 were experimental in nature i.e. evaluating some kind of intervention.
Strengths and limitations
The strengths of this review are that it is the first systematic review focussing on ME research within GCC; due to expected paucity of studies, conference abstracts were reviewed as well as full text journal articles, and thus the search was very comprehensive. While it was difficult to assess the quality of the included abstracts, we used the same criteria as for the full text articles.
Limitations are that no quality threshold was in place and so full text articles as well as abstracts were included if they met inclusion criteria without regard to assessment of their quality. This was done to ensure all potential studies related to ME were included; while it allows us to present a comprehensive picture of research within the GCC it does mean that some included studies were of a higher quality than others. Due to the lack of standardisation, whether in terminology used or type of data collected, or age groups defined as 'adult' or defined as 'child' it was not possible to conduct any form of meta-analysis on the studies identified. A kappa value was not calculated for the quality assessment but the authors ensured that every article included was assessed by two reviewers and any differences were discussed and resolved. Also, the degree or the magnitude of harm caused by improper medication use was not assessed consistently in studies and could not be reported.
Conclusions
This systematic literature review highlights several findings. The first finding is that the literature on ME in the GCC is very diverse, with a wide range of definitions, denominators and measurement approaches. This also meant it was not possible to calculate an overall incidence of medication error. Future studies could be improved to provide wider impact and a clearer rationale. Some suggestions are to enhance coordination between healthcare colleges in the region, and to strengthen research methodologies to increase validity of results and allow them to be placed in context, for example increase follow up studies. Other suggestions are to place more emphasis on research of medication errors in the community pharmacy setting. Increased understanding of patient behavior and medicine management is also justified. Medication error research is generally increasing in the region, several unique issues are noteworthy to be explored for a better understanding of errors occurring and solutions to overcome them. Prescription error Prescription error categories: -Omissions; major omissions, minor omissions -Dose or direction error -Legal requirements not met -Prescription written for a non-prescription product -Unclear quantity prescribed -Incomplete (''As directed or p.r.n") Shaughnessy and Nickel (1989) Khoja et al. (2011 ), Al Khaja et al. (2005 , Al Khaja et al. (2007) Prescribing error A clinically meaningful prescribing error occurs when, as a result of a prescribing decision or prescription writing process, there is an unintentional significant (i) reduction in the probability of treatment being timely and effective (ii) increase in the risk of harm Dean et al. (2000) Al Khaja et al. (2012) , Al-Dhawailie (2011) (continued on next page) An adverse drug event is an injury caused by a medication, which include both adverse drug reactions (an effect which is noxious and unintended, and which occurs at doses used in man for prophylaxis, diagnosis or therapy) as well as harmful effects arising from errors at any stage including ordering, transcribing, dispensing, administering, or monitoring of a drug 
Saudi Arabia
Retrospective cohort study A prescription error was defined per (Kaushal et al. (2001) as well as (Miller et al. (2007) and Lesar et al. (2006) , Abushaiqa et al. (2007) and Kohn et al. (2000) Physical inspection of physician medication and reviews of patients files The study was a review of incorrect drug error reports for 21 month period. Reports were reviewed by two pharmacists to ensure accuracy of data classification
The objective was to explore factors that help pharmacists identify and thus prevent harm from incorrect drug prescribing errors in an ambulatory care setting.
During the specified period 2073 prescribing errors were reported in the hospital safety reporting system. Incorrect drug prescribing errors occurred at a rate of 10% (203 reports DRPs were identified by a researcher reviewing the medical records of children attending the ED during a three month period DRPs incidence in children attending an ED was calculated, preventability was determined and severity assessed
The results from KSA arm of the study: Total Patients (n = 143) Fifty-two DRPs identified; most common types were dosing problems followed by drug choice problems. Fifty-one of the 52 DRPs identified were preventable; and approx. 77% of minor severity Al-Arifi et al.
Saudi Arabia
Prospective cohort observational study Drug related problems (DRP) were defined according to the Information was taken by one of the authors from the patient file and/or patient interviewing using the specially designed data collection sheet
Aims were: -To prospectively determine the incidence and types of emergency department (ED) visits and admissions due to drug related problems (DRPs) at a tertiary hospital -To assess the severity and preventability of the drug related admissions or visits -To identify the drugs and patient groups that are most commonly involved Random selection of 300 patients presenting to emergency department of which, 56 (approx. 19%) were presented to ED due to DRPs. The most common DRPs was due to adverse drug reactions (approx. 30%) and patients' noncompliance (approx. 30%), followed by untreated indication then drug interactions; supratherapeutic and subtherapeutic dose. It was noted that adverse drug reaction incidence was almost double in female patients than male (11:6) Alghamdy et al. (2015) Saudi Arabia
Retrospective review of medical records of selected emergency department admissions
Definitions of DRP: While medication error is defined as (Lisby et al., 2010) and ( Gandhi et al., 2001) ADEs were assessed for causality using the Naranjo algorithm (Naranjo et al., 1981) and for severity and preventability
The incidence of ADEs was calculated and the two different detection methods were compared
The incidence of ADEs detected through surveillance was significantly higher (P < 0.001) than for ADEs reported spontaneously for both inpatients (and outpatients. Most ADEs were judged to be of mild to moderate severity. Approx. 56% of ADEs were judged definite or probable and, of these, approx. 14% were consistently judged preventable. The most prevalent drugs implicated were central nervous system, antiinfective, and cardiovascular agents Aljadhey et al. (2013) a Saudi Arabia
Prospective cohort study ADE as per (Jha et al., 1998) as well as Gandhi et al. (2000) A potential ADE as per (Morimoto et al., 2004) Incidents were identified through a combination of medical record review by study pharmacists and voluntary reports from other Prospective, nonrandomised observational study
An ADE was defined as per (Nebeker et al., 2004 ) ADEs due to medication errors were considered to be preventable, while those caused by adverse drug reactions (without an error) were considered to be nonpreventable. The incidences of ADEs after discharge from the hospital were identified using a questionnaire
The intervention pharmacist comprehensively counselled patients about their discharge medications. The control group included similar patients who received routine discharge counselling by nurses. Two weeks after discharge, the same pharmacist called the patients and assessed the frequency of ADEs. Two independent clinicians reviewed each ADEs and judged its severity and preventability
To assess a program involving comprehensive medication counselling provided by pharmacists at the time of discharge. The study outcome was the incidence of patientreported ADEs after discharge Two hundred patients were included, 100 in the control group and 100 in the intervention group. Approx. 88% (175/200) patients were successfully contacted two weeks after. ADEs occurred in 2 patients in the intervention group and in 21 patients (23 incidents in 21 patients) in the control group (P < .001). 14 ADEs were judged as preventable, and 9 were judged as serious. Warfarin, insulin, antilaxatives and iron supplements were some of the agents involved Rashed et al. (2012) Saudi Arabia A prospective cohort study
Drug-related problems (DRP) defined as per (PCNE) Pharmaceutical Care Network Europe,
Adopted the data collection method of intensive chart review, used by Ghaleb et al. (2010) and by Dean et al. (2002) . For measurement of the severity of the DRPs used validated scale for medication errors published by Dean and Barber (1999 The overall physician attendance for the educational session was 92 from a total of 102 (approx. 90%) A total of 1822 prescriptions were involved in the study, with 948 in the pre sample and 874 in the post sample. The total number of errors within the pre sample was (approx. 20%) in comparison to (approx. 10%) errors for the post sample, an overall reduction of 52% in prescribing errors (P < 0.001) V-Perceptions of HCP on ME and ME reporting (n = 3) Al-Rowibah 
